A Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating Abatacept

NCT01339481 · clinicaltrials.gov ↗

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: abatacept

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]